pharma · Advanced Solid Tumors · Solid Tumor · PYXS
Pyxis Oncology
Pyxis Oncology is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PYXS. Primary therapeutic focus areas include Advanced Solid Tumors, Solid Tumor, Solid Tumors, Advanced solid tumors,
Boston, USA HQ
2019 Founded
71 Employees
Public company Type
PYXS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2019
- Employees
- 71
- Programs
- 8
- Drugs
- 6
- Patents
- 3
PYX-201
Phase 2 · small molecule · Advanced Solid Tumors
PYX-201 for Advanced Solid Tumors is a Phase 2 program (small_molecule) at Pyxis Oncology with 1 ClinicalTrials.gov record(s).
Internal code PYX-201-102
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pyxis Oncology
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced Solid Tumors
- Status
- active
- Trials
- 1